Nuclear medicine play poised to boom
An Australian invention, Cyclopharm’s lung imaging tool Technegas looks to have all the boxes ticked for success in the US.
Stockhead
Recce approved to advance Phase 2 skin infections trial
A key body has unanimously agreed the Phase 2 trial of Recce’s lead compound for acute bacterial skin and skin-structure infections should continue.
Wall Street hypes Big Tech earnings
The ASX is expected to rise as Wall Street gains, driven by upcoming tech earnings, and Altman’s nuclear startup soars.
Unicorns: Restoke.ai ignites new era for restaurants
In this podcast episode, Justin interviews Assaf Stizki and Ken Brand, founders of the restaurant intelligence platform Restoke.ai.
More Stories
Culpeo surfaces thick copper-gold in Chile
Culpeo Minerals says surface trenching at the Fortuna project in Chile has returned 46m at 0.9% copper equivalent.
Uvre executes heritage survey at Frome Downs
The heritage survey agreement covers all of Uvre’s South Australian uranium projects including the Frome Basin and Yankannina projects.
ASX Small Caps Lunch Wrap
Local markets dip on resources sell down as China goes on holiday.
London calling as pot play plans ASX exit
An overwhelming majority of Argent Biopharma shareholders support an ASX delisting in favour of a London presence. Read that and more in today’s Health Check.
Brightstar seals deal to grow gold to 2Moz
Brightstar Resources has acquired the gold rights at the Montague East project from Gateway Mining, bumping its group resources to a whopping 2Moz
Top 10: Fresh from the ASX
Good morning and welcome to Stockhead’s Top 10 at 11, a short, sharp update to help frame the trading day.
September’s ASX health stock standouts
The recent US Federal Reserve rate cut is sparking renewed optimism for the healthcare sector. And things were already looking good for these stocks.
Strong stocks that powered ASX’s September lift
Renewed optimism lifted the S&P/ASX 200 by 3 per cent in September, closing at a record 8239.20 points. These stocks led the way.
Oil stocks on watch as war escalates
Investors could face volatility as crude prices soar to their highest levels in over a year due to escalating tensions in the Middle East.
Why the Big Australian is nuts about copper
BHP believes global copper demand will grow by around 70% to more than 50Mt a year by 2050.
Original URL: https://www.themercury.com.au/business/stockhead/page/76